Interestingly, we found that these four CLRs shared similar pathways, which focused on the positive regulation of the activation and migration of innate and adaptive immunity, which suggests that CLRs potentially provide immunity against bladder cancer. This evidence concerns the gene LARS1 and urinary bladder carcinoma.